Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 22, 2017

DrugPatentWatch Database Preview

Memantine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for memantine hydrochloride and what is the scope of memantine hydrochloride patent protection?

Memantine hydrochloride
is the generic ingredient in three branded drugs marketed by Sun Pharma Global, Unichem Labs Ltd, Amneal Pharms, Forest Labs Llc, Mylan Pharms Inc, Lupin Ltd, Ajanta Pharma Ltd, Silarx Pharms Inc, Apotex Inc, Macleods Pharms Ltd, Upsher-smith Labs, Orchid Hlthcare, Bio-pharm Inc, Dr Reddys Labs Ltd, Teva Pharms, Puracap Pharm Llc, Torrent Pharms Ltd, Wockhardt Ltd, Aurobindo Pharma Ltd, Jubilant Generics, and Alembic Pharms Ltd, and is included in twenty-nine NDAs. There are eight patents protecting this compound and five Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are twenty-eight drug master file entries for memantine hydrochloride. Thirty-six suppliers are listed for this compound. There are three tentative approvals for this compound.

Summary for Generic Name: memantine hydrochloride

Tradenames:3
Patents:8
Applicants:21
NDAs:29
Drug Master File Entries: see list28
Suppliers / Packagers: see list36
Bulk Api Vendors: see list69
Clinical Trials: see list1,070
Patent Applications: see list1,926
Therapeutic Class:Antidementia Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:memantine hydrochloride at DailyMed

Pharmacology for Ingredient: memantine hydrochloride

Tentative approvals for MEMANTINE HYDROCHLORIDE

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe5MGTABLET; ORAL
► Subscribe► Subscribe10MGTABLET; ORAL
► Subscribe► Subscribe10MGTABLET;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Silarx Pharms Inc
MEMANTINE HYDROCHLORIDE
memantine hydrochloride
TABLET;ORAL207236-001Nov 10, 2016ABRXNoNo► Subscribe► Subscribe
Forest Labs Llc
NAMENDA
memantine hydrochloride
TABLET;ORAL021487-001Oct 16, 2003ABRXYesNo► Subscribe► Subscribe
Forest Labs Llc
NAMENDA XR
memantine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL022525-001Jun 21, 2010ABRXYesNo8,168,209*PED► SubscribeY► Subscribe
Jubilant Generics
MEMANTINE HYDROCHLORIDE
memantine hydrochloride
TABLET;ORAL091585-001Oct 13, 2015ABRXNoNo► Subscribe► Subscribe
Amneal Pharms
MEMANTINE HYDROCHLORIDE
memantine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL205825-003Oct 12, 2016ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Formulary management
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot